Stonnington Group LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 7.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,583 shares of the healthcare conglomerate’s stock after purchasing an additional 1,985 shares during the quarter. UnitedHealth Group accounts for approximately 3.5% of Stonnington Group LLC’s investment portfolio, making the stock its 3rd largest holding. Stonnington Group LLC’s holdings in UnitedHealth Group were worth $14,824,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Lincoln National Corp lifted its holdings in shares of UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock worth $4,495,000 after purchasing an additional 1,174 shares during the period. Salvus Wealth Management LLC lifted its holdings in UnitedHealth Group by 23.5% in the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock valued at $399,000 after acquiring an additional 149 shares during the period. YorkBridge Wealth Partners LLC lifted its holdings in UnitedHealth Group by 1.8% in the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $7,681,000 after acquiring an additional 272 shares during the period. Alexandria Capital LLC lifted its holdings in UnitedHealth Group by 3.5% in the third quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock valued at $6,682,000 after acquiring an additional 584 shares during the period. Finally, BOKF NA lifted its holdings in UnitedHealth Group by 3.0% in the fourth quarter. BOKF NA now owns 87,046 shares of the healthcare conglomerate’s stock valued at $43,709,000 after acquiring an additional 2,546 shares during the period. 87.48% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $482.00 to $549.00 and gave the company a “buy” rating in a report on Monday, April 18th. BMO Capital Markets boosted their price objective on UnitedHealth Group from $510.00 to $600.00 and gave the company a “market perform” rating in a research report on Tuesday, April 19th. Barclays boosted their price objective on UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research report on Wednesday, March 30th. Royal Bank of Canada set a $563.00 price objective on UnitedHealth Group and gave the company an “outperform” rating in a research report on Monday, April 18th. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $555.73.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.40 by $0.09. The firm had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. UnitedHealth Group’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.31 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be given a $1.65 dividend. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
In other UnitedHealth Group news, Director Frederick William Mcnabb III acquired 89 shares of the company’s stock in a transaction dated Thursday, May 26th. The shares were acquired at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the acquisition, the director now owns 11,259 shares in the company, valued at approximately $5,678,138.88. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares in the company, valued at approximately $581,936,400. The disclosure for this sale can be found here. 0.40% of the stock is owned by company insiders.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.